The interpretation moved across the clinically actionable boundary since this result was reported.
2023 · On file
Uncertain significance
Reported 20 Mar 2023
Today · ClinVar
Likely pathogenic
ClinVar last evaluated 31 Jul 2025 · Single submitter
Synthetic record. No identifiers in this workspace correspond to a real person.
Novel frameshift change with no public submissions at the time of reporting. Classified as uncertain pending further evidence.
Read from ClinVar at the last evidence sync.
Since the 2023 report, the consensus for MYBPC3 c.776delinsTT has moved from uncertain significance to likely pathogenic. That reading rests on a single submission at limited review confidence, single submitter. That crosses the clinically actionable boundary, so management guidance issued on the original interpretation may no longer be the right guidance. 2 records on file carry this variant and have not yet been reassessed.
Composed from the structured fields of the records cited on this page. Requires clinical verification before it informs any decision.
Global · ClinVar
Likely pathogeniccriteria provided, single submitter · Last evaluated 31 Jul 2025
Regional · Regional Evidence Index
Likely pathogenic0 observations in 3,042 · updated 25 Sept 2026
Sources consistent
Both lanes fall in the same clinical band.
Global
Read from ClinVar, which aggregates submissions dominated by European-ancestry cohorts.
Regional
Modelled regional aggregation maintained inside this workspace.
VariantPulse analysis
Both sources place this variant in the same band, so there is no divergence to resolve. CTGA lists this frameshift in a UAE patient as likely pathogenic for left ventricular non-compaction (record dated 2020). It did not appear in ClinVar until after January 2023 (first classified likely pathogenic, July 2025, single submitter). Another case where a regional catalogue carried the answer before global databases did.
MYBPC3 c.776delinsTT. The DNA is unchanged. The evidence around it is not.